On Dec 30, 2020, Beijing Institute of Biological Products Co Ltd’s inactivated COVID-19 vaccines became the first in China to receive conditional approval for marketing.
Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing
On Dec 30, 2020, Beijing Institute of Biological Products Co Ltd’s inactivated COVID-19 vaccines became the first in China to receive conditional approval for marketing.